Sales for the quarter ended at MNOK 76,2 (MNOK 69,2), resulting in a 10,2 % increase.
Sales for the first half of 2018 increased by 4,7 % and ended at MNOK 150,4 (MNOK 143,5). Currency neutral growth of own products was 19,3 % for the second quarter. Operating profit (EBIT) ended at MNOK 18,1 (MNOK 13,6).
Medistims equipment received an updated recommendation by NICE in UK, and preliminary results from the REQUEST register study was presented at the American Association for Thoracic Surgery (AATS).
Dividend based upon 2017 results was paid the second quarter with MNOK 36,4, NOK 2, 00 per share (NOK 1,75 per share).
Read the full report and financial presentation below: